These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
407 related articles for article (PubMed ID: 11894121)
1. Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: a novel approach in developing effective chemopreventive regimens. Swamy MV; Cooma I; Reddy BS; Rao CV Int J Oncol; 2002 Apr; 20(4):753-9. PubMed ID: 11894121 [TBL] [Abstract][Full Text] [Related]
2. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib. Zhang GS; Liu DS; Dai CW; Li RJ Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520 [TBL] [Abstract][Full Text] [Related]
3. Chemoprevention of familial adenomatous polyposis by low doses of atorvastatin and celecoxib given individually and in combination to APCMin mice. Swamy MV; Patlolla JM; Steele VE; Kopelovich L; Reddy BS; Rao CV Cancer Res; 2006 Jul; 66(14):7370-7. PubMed ID: 16849589 [TBL] [Abstract][Full Text] [Related]
4. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374 [TBL] [Abstract][Full Text] [Related]
5. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455 [TBL] [Abstract][Full Text] [Related]
6. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. Liu X; Yue P; Zhou Z; Khuri FR; Sun SY J Natl Cancer Inst; 2004 Dec; 96(23):1769-80. PubMed ID: 15572759 [TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells. Maier TJ; Schilling K; Schmidt R; Geisslinger G; Grösch S Biochem Pharmacol; 2004 Apr; 67(8):1469-78. PubMed ID: 15041464 [TBL] [Abstract][Full Text] [Related]
8. Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells. Agarwal B; Bhendwal S; Halmos B; Moss SF; Ramey WG; Holt PR Clin Cancer Res; 1999 Aug; 5(8):2223-9. PubMed ID: 10473109 [TBL] [Abstract][Full Text] [Related]
9. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib. Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477 [TBL] [Abstract][Full Text] [Related]
10. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice. Ajith TA; Harikumar KB; Thasna H; Sabu MC; Babitha NV Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106 [TBL] [Abstract][Full Text] [Related]
11. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines. Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902 [TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells. Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664 [TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors. Kusunoki N; Yamazaki R; Kawai S Arthritis Rheum; 2002 Dec; 46(12):3159-67. PubMed ID: 12483719 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of COX-2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53. Swamy MV; Herzog CR; Rao CV Cancer Res; 2003 Sep; 63(17):5239-42. PubMed ID: 14500353 [TBL] [Abstract][Full Text] [Related]
16. A combination of docosahexaenoic acid and celecoxib prevents prostate cancer cell growth in vitro and is associated with modulation of nuclear factor-kappaB, and steroid hormone receptors. Narayanan NK; Narayanan BA; Reddy BS Int J Oncol; 2005 Mar; 26(3):785-92. PubMed ID: 15703837 [TBL] [Abstract][Full Text] [Related]
17. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo. McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488 [TBL] [Abstract][Full Text] [Related]
18. Failure of apoptosis and activation on NFkappaB by celecoxib and aspirin in lung cancer cell lines. Gradilone A; Silvestri I; Scarpa S; Morrone S; Gandini O; Pulcinelli FM; Gianni W; Frati L; Aglianò AM; Gazzaniga P Oncol Rep; 2007 Apr; 17(4):823-8. PubMed ID: 17342322 [TBL] [Abstract][Full Text] [Related]
19. Combination of cyclooxygenase-2 inhibitors and oxaliplatin increases the growth inhibition and death in human colon cancer cells. Lin J; Hsiao PW; Chiu TH; Chao JI Biochem Pharmacol; 2005 Sep; 70(5):658-67. PubMed ID: 16004971 [TBL] [Abstract][Full Text] [Related]
20. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt. Liu B; Shi ZL; Feng J; Tao HM Cell Biol Int; 2008 May; 32(5):494-501. PubMed ID: 18078766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]